Notice: Get a jump on 2015 — Pay your 2015 ASA membership dues now!

>

MEETINGS / EVENTS

RSS

January 23 - 25 2015, 12:00 AM - 12:00 AM

ASA PRACTICE MANAGEMENT 2015

February 07 - 08 2015, 12:00 AM - 12:00 AM

ASA Certificate in Business Administration 2015

June 26 - 28 2015, 12:00 AM - 12:00 AM

Annual Perioperative Surgical Home Summit

>

FDA MEDWATCH ALERTS

December 18, 2014

0.9 Percent Sodium Chloride Injection USP in 100 mL MINI-BAG PLUS Container by Baxter: Recall - Particulate Matter

Summary:

FDA MedWatch Recall - Particulate Matter

November 21, 2014

FDA MedWatch - Respironics California, Esprit V1000 and V200 Ventilators: Class I Recall - Power Failure May Occur

Summary:

FDA MedWatch Respironics California Esprit V1000 and V200 Ventilators Class I Recall

November 21, 2014

FDA MedWatch - Highly Concentrated Potassium Chloride Injection, 10 mEq per 100 mL by Baxter: Recall - Mislabeled

Summary:

Highly Concentrated Potassium Chloride Injection 10 mEq per 100 mL by Baxter Recall Mislabeled

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Self-Education and Evaluation (SEE) Program

SKU: 30701-14CE

... Read more »

Single Copies, Member Price: $360

ASA Convenes Drug Shortage Summit Work Group

Friday, June 24, 2011

At ASA’s Washington, D.C. office on Thursday, June 23, ASA convened the Drug Shortage Summit Legislative and Regulatory Work Group. More than twenty individuals representing health care providers, manufacturers, distributors and wholesalers met to discuss potential regulatory and legislative solutions to the ongoing drug shortages.  ASA was encouraged by the frank and open dialogue between all stakeholders. In the coming weeks, the group hopes to finalize consensus-based recommendations to present publicly.  
 
ASA continues to work closely with the Association Society of Health Systems Pharmacists, the American Society of Clinical Oncology (ASCO) and the American Hospital Association (AHA) who have become leaders on addressing these issues.
 
In addition to actions by this work group, legislation has been introduced to address drug shortages, the Government Accountability Office (GAO) has begun an investigation into shortage, and the Food and Drug Administration (FDA) is planning to hold a drug shortages meeting in September.   
 
Click here to read the latest information on drug shortages.

 

« Back to Washington Alerts